News

MyChesCo on MSN1d
Helius Medical Technologies Secures Fifth Major Payer Authorization for PoNS Device
Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced that CignaHealth has authorized claims for payment of the ...
Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device
CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of ...
Multiple Sclerosis News Today5d
Aetna agrees to reimburse PoNS device for MS patients
Helius Medical Technologies calls the out-of-network reimbursement the first step in making the PoNS device more accessible to MS patients.
MyChesCo on MSN6d
Helius Medical Secures Aetna Approval for PoNS Device Reimbursement
Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced that Aetna Healthcare has authorized a claim for reimbursement for ...
Helius Medical Technologies, Inc.: Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting
PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy® on gait deficit improvement in people with Multiple Sclerosis- -Presentation of ...
The Manila Times6d
Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting
CMSC attendees were encouraged at Helius' recent successes in obtaining initial reimbursement from federal and private payers ...